Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.
<h4>Background</h4>Esophageal cancer is a highly malignant cancer with a very poor prognosis. For resectable esophageal cancer, neoadjuvant treatment could improve the prognosis of esophageal cancer. However, current clinical neoadjuvant treatment options for esophageal cancer are still...
Guardado en:
Autores principales: | Guocan Yu, Wenfeng Yu, Xudong Xu, Bo Ye, Liwei Yao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f234c56c733447bb46ce808453644be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
por: Sonja Gillen, et al.
Publicado: (2010) -
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
por: Jaehyeon Park, et al.
Publicado: (2021) -
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
por: Kamil D. Dalgatov, et al.
Publicado: (2021) -
A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus
por: Yunpeng Zhao, et al.
Publicado: (2021) -
Meta-Analysis of the Association between Asbestos Exposure and Esophageal Cancer
por: Chih-Wei Wu, et al.
Publicado: (2021)